176 related articles for article (PubMed ID: 8698852)
1. Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.
Perreault C; Jutras J; Roy DC; Filep JG; Brochu S
J Clin Invest; 1996 Aug; 98(3):622-8. PubMed ID: 8698852
[TBL] [Abstract][Full Text] [Related]
2. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
[TBL] [Abstract][Full Text] [Related]
3. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens.
Korngold R; Leighton C; Mobraaten LE; Berger MA
Biol Blood Marrow Transplant; 1997 Jun; 3(2):57-64. PubMed ID: 9267665
[TBL] [Abstract][Full Text] [Related]
4. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
5. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras.
Brochu S; Baron C; Hétu F; Roy DC; Perreault C
J Immunol; 1995 Dec; 155(11):5104-14. PubMed ID: 7594519
[TBL] [Abstract][Full Text] [Related]
6. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
7. Immunodominant CD4+ T cell receptor Vbeta repertoires involved in graft-versus-host disease responses to minor histocompatibility antigens.
Berger MA; Korngold R
J Immunol; 1997 Jul; 159(1):77-85. PubMed ID: 9200441
[TBL] [Abstract][Full Text] [Related]
8. The molecular and functional characterization of a dominant minor H antigen, H60.
Malarkannan S; Shih PP; Eden PA; Horng T; Zuberi AR; Christianson G; Roopenian D; Shastri N
J Immunol; 1998 Oct; 161(7):3501-9. PubMed ID: 9759870
[TBL] [Abstract][Full Text] [Related]
9. Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease.
Friedman TM; Gilbert M; Briggs C; Korngold R
J Immunol; 1998 Jul; 161(1):41-8. PubMed ID: 9647205
[TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease.
Fontaine P; Roy-Proulx G; Knafo L; Baron C; Roy DC; Perreault C
Nat Med; 2001 Jul; 7(7):789-94. PubMed ID: 11433342
[TBL] [Abstract][Full Text] [Related]
11. Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease.
Schultz KR; Paquet J; Bader S; HayGlass KT
Bone Marrow Transplant; 1995 Aug; 16(2):289-95. PubMed ID: 7581150
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers.
Schlegel PG; Vaysburd M; Chen Y; Butcher EC; Chao NJ
J Immunol; 1995 Oct; 155(8):3856-65. PubMed ID: 7561092
[TBL] [Abstract][Full Text] [Related]
13. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
Jones SC; Friedman TM; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
[TBL] [Abstract][Full Text] [Related]
14. Minors come of age: Minor histocompatibility antigens and graft-versus-host disease.
Chao NJ
Biol Blood Marrow Transplant; 2004 Apr; 10(4):215-23. PubMed ID: 15077220
[TBL] [Abstract][Full Text] [Related]
15. Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation.
Mori S; El-Baki H; Mullen CA
Bone Marrow Transplant; 2003 May; 31(10):865-75. PubMed ID: 12748663
[TBL] [Abstract][Full Text] [Related]
16. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
17. Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens.
Korngold R; Wettstein PJ
J Immunol; 1990 Dec; 145(12):4079-88. PubMed ID: 2258608
[TBL] [Abstract][Full Text] [Related]
18. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.
Friedman TM; Statton D; Jones SC; Berger MA; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2001; 7(1):2-13. PubMed ID: 11215694
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and immunogenetic analysis of an immunodominant peptide (B6dom1) encoded by the classical H7 minor histocompatibility locus.
Eden PA; Christianson GJ; Fontaine P; Wettstein PJ; Perreault C; Roopenian DC
J Immunol; 1999 Apr; 162(8):4502-10. PubMed ID: 10201988
[TBL] [Abstract][Full Text] [Related]
20. Identification of classical minor histocompatibility antigen as cell-derived peptide.
Wallny HJ; Rammensee HG
Nature; 1990 Jan; 343(6255):275-8. PubMed ID: 1689009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]